For: | Senzolo M, Schiff S, D’Aloiso CM, Crivellin C, Cholongitas E, Burra P, Montagnese S. Neuropsychological alterations in hepatitis C infection: The role of inflammation. World J Gastroenterol 2011; 17(29): 3369-3374 [PMID: 21876628 DOI: 10.3748/wjg.v17.i29.3369] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i29/3369.htm |
Number | Citing Articles |
1 |
M. Hasby Saad, O. Safwat, D. El-Guindy, R. Raafat, D. Elgendy, E. Hasby. Biomolecular changes and cortical neurodegenerative lesions in Trichinella spiralis infected BALB/c mice: a preliminary study elucidating a potential relationship between systemic helminthic infections and idiopathic Parkinson’s. Helminthologia 2018; 55(4): 261 doi: 10.2478/helm-2018-0029
|
2 |
Jéssica Wouk, Daniele Zendrini Rechenchoski, Bianca Cerqueira Dias Rodrigues, Elisa Vicente Ribelato, Ligia Carla Faccin-Galhardi. Viral infections and their relationship to neurological disorders. Archives of Virology 2021; 166(3): 733 doi: 10.1007/s00705-021-04959-6
|
3 |
M. Acebo García-Guerrero, Pedro Sánchez Gómez, Javier Peña Lasa, Joseba Portu Zapirain, Edorta Elizagárate Zabala, Victoria Gorria Bernal, Natalia Ojeda del Pozo. Efecto de los síntomas psiquiátricos y calidad de vida sobre el desempeño cognitivo en el VHC. Revista de Psiquiatría y Salud Mental (English Edition) 2020; 13(1): 22 doi: 10.1016/j.rpsmen.2018.06.002
|
4 |
Kathleen Rosa, Min Fu, Leen Gilles, Karin Cerri, Monika Peeters, Jeffrey Bubb, Jane Scott. Validation of the Fatigue Severity Scale in chronic hepatitis C. Health and Quality of Life Outcomes 2014; 12(1) doi: 10.1186/1477-7525-12-90
|
5 |
Jefferson Abrantes, Daniel Simplicio Torres, Carlos Eduardo Brandão – Mello. The Many Difficulties and Subtleties in the Cognitive Assessment of Chronic Hepatitis C Infection. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/9675235
|
6 |
Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young‐Suk Lim, Ming‐Lung Yu, Norifumi Kawada, Yock Young Dan, Craig Brooks‐Rooney, Francesco Negro, Mario U. Mondelli. The impact of hepatitis C virus outside the liver: Evidence from Asia. Liver International 2017; 37(2): 159 doi: 10.1111/liv.13272
|
7 |
April D. Thames, Steven A. Castellon, Elyse J. Singer, Rajakumar Nagarajan, Manoj K. Sarma, Jason Smith, Nicholas S. Thaler, Jonathan Hien Truong, Daniel Schonfeld, M. Albert Thomas, Charles H. Hinkin. Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurology Neuroimmunology & Neuroinflammation 2015; 2(1) doi: 10.1212/NXI.0000000000000059
|
8 |
Jefferson Abrantes, Daniel Simplício Torres, Carlos Eduardo Brandão de Mello. Patients with hepatitis C infection and normal liver function: an evaluation of cognitive function. Postgraduate Medical Journal 2013; 89(1054): 433 doi: 10.1136/postgradmedj-2012-131185
|
9 |
David P. Sheppard, Steven Paul Woods, Mark W. Bondi, Paul E. Gilbert, Paul J. Massman, Katie L. Doyle. Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?. The Clinical Neuropsychologist 2015; 29(5): 656 doi: 10.1080/13854046.2015.1077995
|
10 |
Amal Tohamy Abdel Moez, Yomna Ahmed El Hawary, Amira Mahmoud Al Balakosy. Can successful treatment by direct-acting antivirals improve depression in chronic HCV patients?. European Journal of Gastroenterology & Hepatology 2021; 33(5): 727 doi: 10.1097/MEG.0000000000001790
|
11 |
Harmanpreet Kaur, Radha K. Dhiman, Anand V. Kulkarni, Madhumita Premkumar, Virendra Singh, Ajay Kumar Duseja, Sandeep Grover, Gagandeep S. Grover, Akash Roy, Nipun Verma, Arka De, Sunil Taneja, Rohit Mehtani, Saurabh Mishra, Harpreet Kaur. Improvement of chronic HCV infection‐related depression, anxiety, and neurocognitive performance in persons achieving SVR‐12: A real‐world cohort study. Journal of Viral Hepatitis 2022; 29(5): 395 doi: 10.1111/jvh.13668
|
12 |
Jessica Faccioli, Silvia Nardelli, Stefania Gioia, Oliviero Riggio, Lorenzo Ridola. Neurological and psychiatric effects of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(29): 4846-4861 doi: 10.3748/wjg.v27.i29.4846
|
13 |
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 2017; 21(3): 517 doi: 10.1016/j.cld.2017.03.007
|
14 |
Jordan E. Cattie, Scott L. Letendre, Steven Paul Woods, Fatma Barakat, William Perry, Mariana Cherner, Anya Umlauf, Donald Franklin, Robert K. Heaton, Tarek Hassanein, Igor Grant. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. Journal of NeuroVirology 2014; 20(6): 561 doi: 10.1007/s13365-014-0265-3
|
15 |
W.‐C. Chiu, Y.‐T. Tsan, S.‐L. Tsai, C.‐J. Chang, J.‐D. Wang, P.‐C. Chen. Hepatitis C viral infection and the risk of dementia. European Journal of Neurology 2014; 21(8): 1068 doi: 10.1111/ene.12317
|
16 |
Saurabh Gupta, Jennifer E. Iudicello, Chuan Shi, Scott Letendre, Adam Knight, Jianhua Li, Patricia K. Riggs, Donald R. Franklin, Nichole Duarte, Hua Jin, J. Hampton Atkinson, Xin Yu, Zunyou Wu, Igor Grant, Robert K. Heaton. Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. Drug and Alcohol Dependence 2014; 137: 29 doi: 10.1016/j.drugalcdep.2013.12.021
|
17 |
Jasmohan S. Bajaj, Daniel M. Forton. Cognitive Improvement After HCV Eradication: Extending the Benefits. Hepatology 2013; 58(2): 480 doi: 10.1002/hep.26481
|
18 |
Roman Shrestha, Pramila Karki, Michael Copenhaver. The Wiley Handbook of Healthcare Treatment Engagement. 2020; : 109 doi: 10.1002/9781119129530.ch6
|
19 |
Susanne Sarkar, Rahul Sarkar, Thomas Berg, Martin Schaefer. Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C. British Journal of Psychiatry 2015; 206(1): 45 doi: 10.1192/bjp.bp.113.141770
|
20 |
Mary Ellen Dias Barbosa, Ana Luiza Zaninotto, Daniel Ferraz de Campos Mazo, Mario Guimarães Pessoa, Cláudia Pinto Marques Souza de Oliveira, Flair José Carrilho, Alberto Queiroz Farias. Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0679-5
|
21 |
David A. Sheridan, S. H. Bridge, M. M. E. Crossey, D. J. Felmlee, H. C. Thomas, R. D. G. Neely, S. D. Taylor-Robinson, M. F. Bassendine. Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency. Metabolic Brain Disease 2014; 29(3): 625 doi: 10.1007/s11011-014-9520-9
|
22 |
Chun-Hsiang Tan, Meng-Chia Chang, Wei-Fang Tsai, Wan-Long Chuang, Jee-Fu Huang, Zu-Yau Lin, Chia-Yen Dai, Ming-Lun Yeh, Chi-Ting Li, Rwei-Ling Yu. Different profiles of neurocognitive impairment in patients with hepatitis B and C virus infections. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14736-3
|
23 |
M. Peters, E. Wehking. Hepatitis C und ihre Auswirkungen auf das Gehirn. Trauma und Berufskrankheit 2012; 14(3): 208 doi: 10.1007/s10039-012-1860-2
|
24 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
25 |
M. Acebo García-Guerrero, Pedro Sánchez Gómez, Javier Peña Lasa, Joseba Portu Zapirain, Edorta Elizagárate Zabala, Victoria Gorria Bernal, Natalia Ojeda del Pozo. Efecto de los síntomas psiquiátricos y calidad de vida sobre el desempeño cognitivo en el VHC. Revista de Psiquiatría y Salud Mental 2020; 13(1): 22 doi: 10.1016/j.rpsm.2018.06.003
|
26 |
Rosa Zampino, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto, Luca Rinaldi, Ciro Romano, Luigi E Adinolfi. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World Journal of Hepatology 2013; 5(10): 528-540 doi: 10.4254/wjh.v5.i10.528
|
27 |
Harmanpreet Kaur, Radha K. Dhiman, Anand V. Kulkarni, Madhumita Premkumar, Virendra Singh, Ajay Duseja, Sandeep Grover, Gagandeep Singh Grover, Akash Roy, Nipun Verma, Arka De, Sunil Taneja, Rohit Mehtani, Saurabh Mishra, Harpreet Kaur. Association of Chronic Hepatitis C Infection Related Depression, Anxiety, and Neurocognitive Performance Achieving SVR-12 with Direct-Acting Antivirals: A Prospective Cohort Study. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3946280
|
28 |
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
|
29 |
Giovanni Oriolo, Laura Blanco-Hinojo, Ricard Navines, Zoe Mariño, David Martín-Hernández, Myriam Cavero, Dolors Gimenez, Javier Caso, Lucile Capuron, Xavier Forns, Jesus Pujol, Ricard Sola, Rocio Martin-Santos. Association of chronic inflammation and perceived stress with abnormal functional connectivity in brain areas involved with interoception in hepatitis C patients. Brain, Behavior, and Immunity 2019; 80: 204 doi: 10.1016/j.bbi.2019.03.008
|
30 |
M. Vera‐Llonch, M. Martin, J. Aggarwal, M. Donepudi, M. Bayliss, T. Goss, Z. Younossi. Health‐related quality of life in genotype 1 treatment‐naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study. Alimentary Pharmacology & Therapeutics 2013; 38(2): 124 doi: 10.1111/apt.12354
|
31 |
Yu Fang, Chung-Yu Chen, Hsien-Chung Yu, Pei-Chin Lin. Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1191843
|
32 |
Hossein Nasr Azadani, Mohssen Nassiri Toosi, Shohreh Shahmahmoodi, Ahmad Nejati, Hamzeh Rahimi, Mohammad Farahmand, Abolfazl Keshavarz, Fatemeh Ghorbani Motlagh, Katayoun Samimi-Rad. New insights into potential biomarkers and their roles in biological processes associated with hepatitis C-related liver cirrhosis by hepatic RNA-seq-based transcriptome profiling. Virus Research 2024; 349: 199457 doi: 10.1016/j.virusres.2024.199457
|
33 |
Nobendu Mukerjee, Somdatta Y. Chaudhari, Swastika Jha, Shweta Sinha, Shailaja B. Jadhav, Rajib Dhar, Vivek D. Rathod, Rajesh B. Nanaware, Rita D. Chakole, Devesh Sharma, Prince Prashant Sharma, Sonali D. Pawar, Arabinda Ghosh. Emerging hepatitis C virus and neuron-allied neuroviral intertwine and its therapeutic approaches. International Journal of Surgery 2023; 109(6): 1810 doi: 10.1097/JS9.0000000000000074
|
34 |
Pegah Golabi, Elzafir Elsheikh, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M. Younossi. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV). Medicine 2016; 95(46): e5066 doi: 10.1097/MD.0000000000005066
|
35 |
Alexandra Pham-Scottez, Valérie Dauriac-Le Masson, Oumeyma Ben Dahman, Armel Toquin, Amine Benmostefa, Nabil Hallouche. Retrospective study of hepatitis C screening and seroprevalence in the GHU Paris. L'Encéphale 2024; doi: 10.1016/j.encep.2024.05.002
|
36 |
M. M. Bassiony, A. Yousef, Y. Raya, A. El-Shabrawi, E. Fouad, M. El-Shafeey. Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt. International Journal of Psychiatry in Clinical Practice 2015; 19(3): 208 doi: 10.3109/13651501.2015.1064964
|
37 |
Ahmed Esmael, Tamer Belal, Ibrahim F. Amer, Eslam Samra, Azza Elmongui, Saad Shawki. Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2022; 58(1) doi: 10.1186/s41983-022-00450-4
|
38 |
Ghulam M. Ashraf, Vadim V. Tarasov, Alfiya Makhmutovа, Vladimir N. Chubarev, Marco Avila-Rodriguez, Sergey O. Bachurin, Gjumrakch Aliev. The Possibility of an Infectious Etiology of Alzheimer Disease. Molecular Neurobiology 2019; 56(6): 4479 doi: 10.1007/s12035-018-1388-y
|
39 |
I. T. Lichtwark, E. D. Newnham, S. R. Robinson, S. J. Shepherd, P. Hosking, P. R. Gibson, G. W. Yelland. Cognitive impairment in coeliac disease improves on a gluten‐free diet and correlates with histological and serological indices of disease severity. Alimentary Pharmacology & Therapeutics 2014; 40(2): 160 doi: 10.1111/apt.12809
|
40 |
Luigi Elio Adinolfi, Riccardo Nevola, Giacomo Lus, Luciano Restivo, Barbara Guerrera, Ciro Romano, Rosa Zampino, Luca Rinaldi, Ausilia Sellitto, Mauro Giordano, Aldo Marrone. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology 2015; 21(8): 2269-2280 doi: 10.3748/wjg.v21.i8.2269
|
41 |
Laura Gragnani, Serena Lorini, Lorenzo Martini, Cristina Stasi, Marcella Visentini, Luisa Petraccia, Niccolò Marello, Monica Monti, Silvia Marri, Francesco Madia, Valdo Ricca, Anna Linda Zignego. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis. Clinical Rheumatology 2022; 41(1): 147 doi: 10.1007/s10067-021-05877-3
|
42 |
Sean P Kennelly. Cognitive dysfunction: an important extrahepatic manifestation of hepatitis C infection?. Postgraduate Medical Journal 2013; 89(1054): 431 doi: 10.1136/postgradmedj-2012-131337
|
43 |
Xiao Jing Wang, Anjana A. Pillai. Extrahepatic Manifestations of Chronic Hepatitis C Infection: a Review and Update. Current Hepatology Reports 2016; 15(3): 150 doi: 10.1007/s11901-016-0309-7
|
44 |
Joanna Bladowska, Anna Zimny, Brygida Knysz, Krzysztof Małyszczak, Anna Kołtowska, Paweł Szewczyk, Jacek Gąsiorowski, Michał Furdal, Marek J. Sąsiadek. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: A pilot study. Journal of Hepatology 2013; 59(4): 651 doi: 10.1016/j.jhep.2013.05.008
|
45 |
Cassio Santos‐Lima, Breno Souza‐Marques, Flávia Vieira, Maria Isabel Schinoni, Lucas C. Quarantini, Neander Abreu. Neuropsychological effects of direct‐acting antiviral treatment for Hepatitis C virus subjects: A systematic review. Journal of Viral Hepatitis 2021; 28(12): 1672 doi: 10.1111/jvh.13584
|
46 |
Daniel M. Forton. Hepatitis C treatment – Clearing the mind. Journal of Hepatology 2012; 56(3): 513 doi: 10.1016/j.jhep.2011.11.004
|
47 |
Ibtihal Ibrahim, Hala Salah, Hanan El Sayed, Hader Mansour, Ahmed Eissa, Joel Wood, Warda Fathi, Salwa Tobar, Ruben C. Gur, Raquel E. Gur, Faith Dickerson, Robert H Yolken, Wafaa El Bahaey, Vishwajit Nimgaonkar. Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample. Journal of Clinical and Experimental Neuropsychology 2016; 38(8): 861 doi: 10.1080/13803395.2016.1168780
|
48 |
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
|
49 |
Hania S. Zayed, Amr Amin, Samy Alsirafy, Nahla D. Elsayed, Soheir Abo Elfadl, Mohamed Nasreldin, Dalia Enaba, Zeinab Nawito. Psychiatric and functional neuroimaging abnormalities in chronic hepatitis C virus patients: Is vasculitis a contributing factor?. Arab Journal of Gastroenterology 2018; 19(2): 71 doi: 10.1016/j.ajg.2018.06.003
|
50 |
Pegah Golabi, Mehmet Sayiner, Haley Bush, Lynn H. Gerber, Zobair M. Younossi. Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection. Clinics in Liver Disease 2017; 21(3): 565 doi: 10.1016/j.cld.2017.03.011
|
51 |
Samuel C. Gable, Maureen K. O’Connor. Caring for Latinxs with Dementia in a Globalized World. 2020; : 69 doi: 10.1007/978-1-0716-0132-7_4
|
52 |
Maria Rita Polo GASCON, Glaucia Rosana Guerra BENUTE, Elizeu Coutinho MACEDO, Claudio Garcia CAPITÃO, José Ernesto VIDAL, Jerusa SMID, Rosa Maria Nascimento MARCUSSO, Mara Cristina Souza de LUCIA, Augusto Cesar PENALVA-DE-OLIVEIRA, Decio DIAMENT. Cognitive assessment in patients with Hepatitis C submitted to treatment with Sofosbuvir and Simeprevir or Daclatasvir. Arquivos de Neuro-Psiquiatria 2020; 78(6): 342 doi: 10.1590/0004-282x20200022
|
53 |
Tatiana Lins Carvalho, Raul Emídio Lima, Gustavo Henrique Belarmino Góes, Lívio Amaro Pereira, Matheus Santos de Sousa Fernandes, Patrícia Muniz Mendes Freire Moura, Luydson Richardson Silva Vasconcelos, Carolina Cunha Correia. Cognitive Dysfunction and Single Nucleotide Polymorphisms in Hepatitis C Virus-Infected Persons: A Systematic Review. Viral Immunology 2017; 30(10): 703 doi: 10.1089/vim.2017.0084
|
54 |
Sofia Volpato, Sara Montagnese, Alberto Zanetto, Matteo Turco, Michele De Rui, Alberto Ferrarese, Piero Amodio, Giacomo Germani, Marco Senzolo, Martina Gambato, Francesco Paolo Russo, Patrizia Burra. Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study. BMJ Open Gastroenterology 2017; 4(1): e000183 doi: 10.1136/bmjgast-2017-000183
|
55 |
Jefferson Abrantes, Daniel Simplicio Torres, Carlos Eduardo Brandão-Mello, Fredric D. Gordon. Patients with Hepatitis C Infection and Normal Liver Function: A Neuropsychological and Neurophysiological Assessment of Cognitive Functions. International Journal of Hepatology 2021; 2021: 1 doi: 10.1155/2021/8823676
|
56 |
Vaughn E. Bryant, Christopher W. Kahler, Kathryn N. Devlin, Peter M. Monti, Ronald A. Cohen. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care 2013; 25(10): 1308 doi: 10.1080/09540121.2013.764965
|
57 |
Sérgio Monteiro de Almeida, Ana Paula de Pereira, Maria Lucia Alves Pedroso, Clea E. Ribeiro, Indianara Rotta, Bin Tang, Anya Umlauf, Donald Franklin, Rowan G. Saloner, Maria Geny Ribas Batista, Scott Letendre, Robert K. Heaton, Ronald J. Ellis, Mariana Cherner. Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil. Journal of NeuroVirology 2018; 24(3): 339 doi: 10.1007/s13365-018-0617-5
|
58 |
Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, Mark Watling, Bruno P Imbimbo. Time to test antibacterial therapy in Alzheimer’s disease. Brain 2019; doi: 10.1093/brain/awz244
|
59 |
Mark K. Britton, Eric C. Porges, Vaughn Bryant, Ronald A. Cohen. Neuroimaging and Cognitive Evidence for Combined HIV‐Alcohol Effects on the Central Nervous System: A Review. Alcoholism: Clinical and Experimental Research 2021; 45(2): 290 doi: 10.1111/acer.14530
|
60 |
Johann Sellner, Israel Steiner. Neurovirology. Handbook of Clinical Neurology 2014; 123: 647 doi: 10.1016/B978-0-444-53488-0.00031-6
|
61 |
G. Oriolo, E. Egmond, Z. Mariño, M. Cavero, R. Navines, L. Zamarrenho, R. Solà, J. Pujol, N. Bargallo, X. Forns, R. Martin‐Santos. Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infection. Alimentary Pharmacology & Therapeutics 2018; 47(9): 1238 doi: 10.1111/apt.14594
|
62 |
Ciro Romano, Giovanna Cuomo, Roberta Ferrara, Andrea Del Mastro, Sergio Esposito, Ausilia Sellitto, Luigi Elio Adinolfi. Uncommon immune-mediated extrahepatic manifestations of HCV infection. Expert Review of Clinical Immunology 2018; 14(12): 1089 doi: 10.1080/1744666X.2018.1538790
|
63 |
Sinda Makhlouf, Mariem Messelmani, Jamel Zaouali, Ridha Mrissa. Cognitive impairment in celiac disease and non-celiac gluten sensitivity: review of literature on the main cognitive impairments, the imaging and the effect of gluten free diet. Acta Neurologica Belgica 2018; 118(1): 21 doi: 10.1007/s13760-017-0870-z
|